How digital is reversing fortunes in R&DA new report lays out the ways digital transformation could reverse the trend of declining ROI in pharma Share XHow digital is reversing fortunes in R&Dhttps://pharmaphorum.com/views-analysis-digital/digital-reversing-fortunes-rd/
Roche, big data and patient outcomes: the pharmaphorum podcastIn the first pharmaphorum podcast of 2020 Roche’s Conor Megaw talks about his company’s approach to big data Share XRoche, big data and patient outcomes: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/roche-big-data-and-patient-outcomes/
Novartis taps Microsoft’s AI expertise for drug developmentNovartis has forged an alliance with Microsoft that will apply artificial intelligence and machine-learning to the discovery, development Share XNovartis taps Microsoft’s AI expertise for drug developmenthttps://pharmaphorum.com/news/novartis-taps-microsofts-ai-expertise-for-drug-development/
How can biotechnology, pharmaceutical and medical device companies achieve the full potential of content personalisation?By Carlos Casanova Healthcare and life sciences companies have an unrealised opportunity to maximise the benefits of personalising Share XHow can biotechnology, pharmaceutical and medical device companies achieve the full potential of content personalisation?https://pharmaphorum.com/views-analysis-sales-marketing/full-potential-content-personalisation/
The top 10 ways digital will transform healthcareJanssen’s Kris Sterkens gives his thoughts on how digital will continue to influence healthcare in the age of Share XThe top 10 ways digital will transform healthcarehttps://pharmaphorum.com/views-analysis-digital/the-top-10-ways-digital-will-transform-healthcare/
Company profile: EvideraData disruption and applying ‘enabled intelligence’ to convert the promise shown in clinical trials into real-world success. For Share XCompany profile: Eviderahttps://deep-dive.pharmaphorum.com/magazine/disruptive-technologies/data-disruption-and-applying-enabled-intelligence/
Predictions for 2019: Ten trends that will shape the future of drug development and commercializationeBook Provides Biopharma Decision Makers With What’s Next Insights to Navigate Challenges and Capitalize on the Opportunities Ahead Share XPredictions for 2019: Ten trends that will shape the future of drug development and commercializationhttps://pharmaphorum.com/partner-content/press-releases/predictions-for-2019-ten-trends-that-will-shape-the-future-of-drug-development-and-commercialisation/
Digital tech crucial to success of cancer cell therapy – NovartisNovartis CEO Vas Narasimhan has made use of digital technology to support patients taking the company’s medicines a Share XDigital tech crucial to success of cancer cell therapy – Novartishttps://pharmaphorum.com/news/digital-tech-crucial-to-success-of-cancer-cell-therapy-novartis/
Finding stories in data: how can all learn to speak the same language?Communication is key when talking about tearing down barriers to data collection or explaining risk and benefits. We Share XFinding stories in data: how can all learn to speak the same language?https://pharmaphorum.com/views-analysis-patients/finding-stories-data-collection/
